Dr. Beth Overmoyer, director of the Inflammatory Breast Cancer Program at Dana-Farber Cancer Institute
Dr. Beth Overmoyer
Search the Blog
-
-
Recent Posts
- Classes Help Survivors Move Beyond Cancer
- Improving Care for Brain Tumor Patients
- What’s the Difference Between Cancer Grade and Cancer Stage?
- Clinical Trials for Cancer Patients
- Should Boys and Girls Be Vaccinated Against HPV?
- Fertility Treatment and Cancer: Is There a Link?
- A User’s Guide to Cancer-Related News
- Facing First-Time Parenthood… and Cancer
- Kelley Tuthill’s Tips for Choosing a Wig
- Summer Fun for Kids with Cancer
- Meet Boston Marathon Runner and Platelet Donor Wendy Akeson
- How to Enjoy Summer without Raising Your Cancer Risk
Categories
- Cancer research (46)
- Care for adults (91)
- Care for children (43)
- General interest (40)
- Health and wellness (41)
- Uncategorized (26)
Tags
BoneMarrowTransplant BrainTumors BreastCancer CancerDisparities CancerPrevention CancerResearch CancerRisk CancerSurvivorship Chemotherapy ChildhoodCancer ChildhoodCancerSurvivorship ClinicalTrials ColonCancer Dana-Farber Exercise Fertility Genetics Genomics HeadandNeckCancer HodgkinLymphoma HPV ImmuneSystem Leukemia LifeWithCancer LungCancer Melanoma MultipleMyeloma Myelodysplastic Syndrome Nursing Nutrition OvarianCancer PatientEducation PatientSafety PatientSupport PediatricOncologist platelets ProstateCancer Radiation Sarcoma SidneyFarber StemCellTransplant Survivor Susan F. Smith Center for Women's Cancers YawkeyCenter YoungAdultsCancerArchives
- June 2013 (7)
- May 2013 (15)
- April 2013 (9)
- March 2013 (10)
- February 2013 (8)
- January 2013 (12)
- December 2012 (9)
- November 2012 (10)
- October 2012 (11)
- September 2012 (10)
- August 2012 (14)
- July 2012 (9)
- June 2012 (14)
- May 2012 (11)
- April 2012 (10)
- March 2012 (9)
- February 2012 (11)
- January 2012 (9)
- December 2011 (7)
- November 2011 (3)
Dana-Farber Website Links
Patient and Family Blogs
All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.
Copyright 2013 Dana-Farber Cancer Institute